George Chressanthis brings almost 25 years of pharmaceutical industry knowledge and experience gained through working within companies advising senior executive teams, functioning as an outside consultant, and conducting research as an academic. He also holds a Ph.D. in economics from Purdue University and earned a full professorship in economics with tenure and graduate faculty status at Mississippi State University prior to his pharmaceutical career.
June 17, 2020
Do pharma mergers and acquisitions improve R&D productivity and increase shareholder value?
0 min read
February 18, 2019
The CVS-Aetna merger could be a transformative event for the pharmaceutical industry. Shrewd negotiating decisions, analytics and real world evidence have never been more important.
0 min read
January 31, 2019
The 2018 Congressional midterm elections are over: the US is back to divided government. And with Democrats controlling the House, and Republicans expanding their majority in the Senate, the US pharma industry could be the number one target for politicians.
0 min read
August 17, 2016
Is leaving the EU a foolish or admirable decision? The UK still has a way to go before the shape of Brexit becomes clear, but the pharma industry can succeed if the right policies are put in place.
1 min read
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
